Company Profile

Genaissance Pharmaceuticals Inc (AKA: BIO Pharmaceuticals Inc)
Profile last edited on: 1/25/2019      CAGE: 3RAM3      UEI: ----------

Business Identifier: Population genomics database
Year Founded
1988
First Award
1989
Latest Award
2011
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5 Science Park
New Haven, CT 06511
   (203) 773-1450
   contact-us@genaissance.com
   www.genaissance.com
Location: Multiple
Congr. District: 03
County: New Haven

Public Profile

Originally receiving SBIR support as BIO Pharmaceuticals Inc, Genaissance Pharmaceuticals, Inc. reflects the extensive movement within the biotech space. In 2005 Genaissance was acquired by Clinical Data Inc which was itself acquired by Allergan which became part of the complex international transaction that involved Pfizer and the new entity Actavis, Plc. With close ties to Yale, the firm Genaissance Pharmaceuticals, Inc. was involved in developing personalized medicines through the integration of pharmacogenomics into drug development and marketing. The Company developed a combination of technologies and expertise, called HAP Technology, which allows population genomics to be integrated into the development, marketing and prescribing of new and existing medicines. The key components of the HAP Technology are a database of highly informative, proprietary measures of genomic variation, or haplotypes; a proprietary informatics system, which is called DECOGEN; a process for measuring genomic variation in clinical DNA samples, and clinical genetics development skills.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
250-500
Revenue Range
20M-50M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : GNSC
IP Holdings
25-49

Awards Distribution by Agency

Key People / Management

  Gerald Vovis -- President

  Carl Balezentis

  Donald Benson

  Kevin L Bentley

  Jurgen Drews -- Chairman

  Clark Huckaby

  Ben Kaplan

  Richard Kouri

  Marcia Lewis

  Wan-Liang Li

  Kevin Rakin -- Founder and President

  Carol Reed

Company News

There are no news available.